CD5-positive, cyclinD1-negative mantle cell lymphoma with a translocation involving the CCND2 gene and the IGL locus

Cancer Genetics

Volumn 204, Issue 3, 2011, Pages 162-164

  Shiller, Shirley Michelle ^a   Zieske, Arthur ^b   Holmes III, Houston ^c   Feldman, Andrew L ^d   Law, Mark E ^d   Saad, Rana ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^d MAYO CLINIC   (United States)

Author keywords

CyclinD2; Mantle cell lymphoma; Translocation

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD5 ANTIGEN; CYCLIN D1; LEUKOSIALIN; CCND2 PROTEIN, HUMAN; CYCLIN D2; IMMUNOGLOBULIN LAMBDA CHAIN;

ADULT; ARTICLE; BONE MARROW BIOPSY; CANCER STAGING; CANCER SURVIVAL; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CYCLIN D2 IMMUNOGLOBULIN LAMBDA LIGHT CHAIN FUSION GENE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE LOCUS; GENE OVEREXPRESSION; GENE TRANSLOCATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL; RECTUM HEMORRHAGE; RECTUM RESECTION; B CELL LYMPHOMA; BIOSYNTHESIS; BONE MARROW CANCER; CHROMOSOME 12; CHROMOSOME 22; DIFFERENTIAL DIAGNOSIS; GASTROINTESTINAL TUMOR; GENETICS; METABOLISM; MIDDLE AGED;

ANTIGENS, CD5; BONE MARROW NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 22; CYCLIN D1; CYCLIN D2; DIAGNOSIS, DIFFERENTIAL; GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNOGLOBULIN LAMBDA-CHAINS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, B-CELL; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; TRANSLOCATION, GENETIC;

EID: 79960672378     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2010.08.016     Document Type: Article

References (8)

1. Fu K., Weisenburger D.D., Greiner T.C., et al. Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood 2005, 106:4315-4321.
2. Gesk S., Klapper W., Martin-Subero J., et al. A chromosomal translocation in cyclin D1-negative/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus. Blood 2006, 108:1109-1110.
3. Herens C., Lambert F., Quintanilla-Martinez L., et al. Cyclin D1-negative mantle cell lymphoma with cryptic t(12;14)(p14;q32) and cyclin D2 overexpression. Blood 2008, 111:1745-1746.
4. Remstein E.D., Dogan A., Einerson R.R., et al. The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America. Am J Surg Pathol 2006, 30:1546-1553.
5. Remstein E.D., Law M., Mollejo M., et al. The prevalence of IG translocations and 7q32 deletions in splenic marginal zone lymphoma. Leukemia 2008, 22:1268-1272.
6. Feldman A.L., Law M., Grogg K.L., et al. Incidence of TCR and TCL1 gene translocations and isochromosome 7q in peripheral T-cell lymphomas using fluoresence in situ hybridization. Am J Clin Pathol 2008, 130:178-185.
7. Qian L., Gong J., Liu J., et al. Cyclin D2 promoter disrupted by t(12;22)(p13;q11.2) during transformation of chronic lymphocytic leukemia to non-Hodgkin's lymphoma. Br J Haematol 1999, 106:477-485.
8. Marzec M., Kasprzycka M., Lai R., et al. Mantle cell lymphoma cells express predominantly cyclin D2a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity. Blood 2006, 108:1744-1750.